Clinical Trials Directory

Trials / Completed

CompletedNCT00000359

Treatments for Benign Paroxysmal Positional Vertigo (BPPV)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Baylor College of Medicine · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to determine the relative short- and long-term efficacy of several physical treatment paradigms commonly employed for the treatment of benign paroxysmal positional vertigo (BPPV), including the canalith repositioning (Epley) maneuver, the liberatory (Semont) maneuver, the Brandt-Daroff exercises and nonspecific vestibular habituation exercises. These procedures involve exercises and head manipulations. Vertigo intensity and frequency, the presence/absence of slow-phase eye movements, the degree of dizziness handicap and acts of daily living (ADL) were assessed. The study also ascertained the effects of co-morbid conditions on the response to treatment. While BPPV is a common and significant public health problem that has been recognized for several decades, this is the first systematic study of the relative treatment efficacy of different physical treatment modalities for this disorder.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCanalith repositioning maneuver (Epley maneuver)Standard passive motion of the head: Dix-Hallpike maneuver, turn head to opposite side, roll over, sit up.
BEHAVIORALSemont maneuverSidelying maneuver, flip over 180 deg, sit up.
BEHAVIORALBrandt-Daroff exercisesActive exercise. Sidelying to involved side, sidelying to uninvolved side, sit up.
BEHAVIORALVestibular habituation exercisesHead shaking exercises in pitch, roll, yaw and circumduction. Titrating from 2 repetitions per exercise to 20 repetitions per exercise, as tolerated.
BEHAVIORALShamManeuverPassive movement of the head

Timeline

Start date
1998-10-01
Primary completion
2003-06-01
Completion
2003-06-01
First posted
1999-11-03
Last updated
2012-07-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000359. Inclusion in this directory is not an endorsement.